Jörg Timm Selected Research

Jörg Timm Research Topics

Disease

35	Infections 01/2023 - 07/2007
8	COVID-19 01/2023 - 01/2020
7	Persistent Infection 01/2019 - 04/2008
6	Hepatitis C 01/2017 - 11/2010
5	Virus Diseases (Viral Diseases) 01/2019 - 01/2013
4	Chronic Hepatitis C 01/2017 - 11/2010
2	Renal Insufficiency (Renal Failure) 01/2021 - 10/2018
2	Reinfection 03/2017 - 05/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Syphilis 11/2021
1	Castleman Disease (Castleman's Disease) 10/2021
1	Chronic Renal Insufficiency 05/2021
1	Body Weight (Weight, Body) 05/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2021
1	Pneumonia (Pneumonitis) 05/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021
1	Diabetes Mellitus 05/2021
1	Transfusion Reaction 05/2021
1	Disease Progression 05/2021
1	IgA Deficiency 05/2021
1	Neoplasms (Cancer) 05/2021
1	Pancreatitis 05/2021
1	Hypersensitivity (Allergy) 05/2021
1	Sclerosing Cholangitis 05/2021
1	Human Influenza (Influenza) 01/2021
1	Fever (Fevers) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2019
1	Needlestick Injuries (Needlestick Injury) 01/2019
1	Ankylosing Spondylitis 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hepatitis D 01/2018
1	Fibrosis (Cirrhosis) 03/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2012
1	Hepatitis 11/2012
1	Liver Diseases (Liver Disease) 11/2012

Drug/Important Bio-Agent (IBA)

10	EpitopesIBA 01/2022 - 07/2007
7	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2015
6	VaccinesIBA 01/2023 - 01/2018
5	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2012
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2019 - 01/2010
3	AntibodiesIBA 05/2021 - 09/2015
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 01/2010
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 01/2014
3	Ribavirin (Virazole)FDA LinkGeneric 03/2017 - 11/2010
2	BNT162 VaccineIBA 12/2021 - 01/2021
2	AntigensIBA 11/2021 - 01/2019
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 01/2019
2	LigandsIBA 10/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2008
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	InterferonsIBA 03/2017 - 11/2010
2	EnzymesIBA 01/2016 - 11/2012
2	Immunoglobulin G (IgG)IBA 10/2015 - 11/2012
2	Immunodominant EpitopesIBA 01/2013 - 02/2009
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2010 - 02/2009
1	sotrovimabIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	Hepatitis B e AntigensIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Capsules (Microcapsules)IBA 05/2021
1	camostatIBA 05/2021
1	Oxygen (Dioxygen)IBA 05/2021
1	2019-nCoV Vaccine mRNA-1273IBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	Interleukin-22 (IL-22)IBA 12/2019
1	Antiviral Restriction FactorsIBA 12/2019
1	HLA-C Antigens (HLA-C)IBA 10/2019
1	AminopeptidasesIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Viral ProteinsIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	MTOR InhibitorsIBA 02/2018
1	CEACAM1 ProteinIBA 01/2018
1	Interferon Type IIBA 11/2017
1	SofosbuvirIBA 03/2017
1	HLA-Bw4 antigenIBA 01/2017
1	telaprevirIBA 05/2015
1	Peptide Hydrolases (Proteases)FDA Link 05/2015
1	SimeprevirIBA 01/2015
1	daclatasvirIBA 01/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 11/2010
4	Liver Transplantation 03/2017 - 11/2012
2	Kidney Transplantation 01/2021 - 01/2017
1	Organ Transplantation 01/2023
1	Cannula 05/2021
1	Contraindications 05/2021
1	Aftercare (After-Treatment) 05/2021
1	Home Nursing (Nursing, Home) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	CT protocol 01/2020
1	Stem Cell Transplantation 12/2019
1	Transplantation 01/2017